Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry A Greenbaum

Showing results (41-50 of 170) with videos related to

Pageof 17
Sort By:
Journal of Pediatric Urology|January 31, 2022
Risk factors for renal scarring and clinical morbidity in children with high-grade and low-grade primary vesicoureteral refluxSitarah Mathias, Larry A Greenbaum, A M Shubha, et al.
Pediatric Nephrology (Berlin, Germany)|August 15, 2021
Randomized trial of two maintenance doses of vitamin D in children with chronic kidney diseaseShahid Nadeem, Vin Tangpricha, Thomas R Ziegler, et al.
Kidney International Reports|February 22, 2021
Grip Strength in Adults and Children with CystinosisHelina Iyob-Tessema, Chia-Shi Wang, Sabina Kennedy, et al.
Pediatric Nephrology (Berlin, Germany)|April 10, 2019
Association between BMI changes and mortality risk in children with end-stage renal diseaseMatthew J Roberts, Mark M Mitsnefes, Charles E McCulloch, et al.
Journal of the American Society of Nephrology : JASN|September 8, 2012
Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIADEric Carpentier, Larry A Greenbaum, Driss Rochdi, et al.
Pediatric Nephrology (Berlin, Germany)|October 13, 2020
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumabKazuki Tanaka, Brigitte Adams, Alvaro Madrid Aris, et al.
Pediatric Nephrology (Berlin, Germany)|June 11, 2021
Patterns of recombinant growth hormone therapy use and growth responses among children with chronic kidney diseaseDerek K Ng, Megan K Carroll, Frederick J Kaskel, et al.
The Journal of Pediatrics|April 5, 2014
The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney diseaseJoseph T Flynn, Derek K Ng, Grace J Chan, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|May 29, 2014
Barriers, biases, and beliefs about arteriovenous fistula placement in children: a survey of the International Pediatric Fistula First Initiative (IPFFI) within the Midwest Pediatric Nephrology Consortium (MWPNC)Deepa H Chand, Denis Geary, Hiren Patel, et al.
Lupus|May 15, 2021
Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research ConsortiumSamar A Soliman, Anam Haque, Sherene Mason, et al.
Pageof 17

Showing results (41-50 of 170) with videos related to

Sort By:
Pageof 17
Journal of Pediatric Urology|January 31, 2022
Risk factors for renal scarring and clinical morbidity in children with high-grade and low-grade primary vesicoureteral refluxSitarah Mathias, Larry A Greenbaum, A M Shubha, et al.
Pediatric Nephrology (Berlin, Germany)|August 15, 2021
Randomized trial of two maintenance doses of vitamin D in children with chronic kidney diseaseShahid Nadeem, Vin Tangpricha, Thomas R Ziegler, et al.
Kidney International Reports|February 22, 2021
Grip Strength in Adults and Children with CystinosisHelina Iyob-Tessema, Chia-Shi Wang, Sabina Kennedy, et al.
Pediatric Nephrology (Berlin, Germany)|April 10, 2019
Association between BMI changes and mortality risk in children with end-stage renal diseaseMatthew J Roberts, Mark M Mitsnefes, Charles E McCulloch, et al.
Journal of the American Society of Nephrology : JASN|September 8, 2012
Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIADEric Carpentier, Larry A Greenbaum, Driss Rochdi, et al.
Pediatric Nephrology (Berlin, Germany)|October 13, 2020
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumabKazuki Tanaka, Brigitte Adams, Alvaro Madrid Aris, et al.
Pediatric Nephrology (Berlin, Germany)|June 11, 2021
Patterns of recombinant growth hormone therapy use and growth responses among children with chronic kidney diseaseDerek K Ng, Megan K Carroll, Frederick J Kaskel, et al.
The Journal of Pediatrics|April 5, 2014
The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney diseaseJoseph T Flynn, Derek K Ng, Grace J Chan, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|May 29, 2014
Barriers, biases, and beliefs about arteriovenous fistula placement in children: a survey of the International Pediatric Fistula First Initiative (IPFFI) within the Midwest Pediatric Nephrology Consortium (MWPNC)Deepa H Chand, Denis Geary, Hiren Patel, et al.
Lupus|May 15, 2021
Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research ConsortiumSamar A Soliman, Anam Haque, Sherene Mason, et al.
Pageof 17